CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 33 filers reported holding CATALYST BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $13,285,000 | – | 514,917 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $32,290 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $16 | 0.01% |
| Kynam Capital Management, LP | 90,058 | $43,435 | 0.01% |
| Nantahala Capital Management | 67,800 | $32,700 | 0.00% |
| Arete Wealth Advisors, LLC | 10,845 | $5,230 | 0.00% |
| MORGAN STANLEY | 97,745 | $47,142 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 63,793 | $30 | 0.00% |
| BlackRock Inc. | 153,759 | $74,158 | 0.00% |
| Citadel Advisors | 1,100 | $531 | 0.00% |
| Citadel Advisors | 47,966 | $23,134 | 0.00% |